High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for <scp> <i>Helicobacter pylori</i> </scp> infection in Northwest China: A prospective, randomised controlled trial-Reference-Cited by-同舟云学术

High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial

Published:2022-08-21 Issue:1 Volume:89 Page:232-241
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Yun Jian‐Wei¹²^ORCID,Wang Cui³,Yu Yi¹,Xu Hui‐Mei¹²,Gou Ling‐Zhu¹²^ORCID,Li Xiao‐Li¹²,Yi Gui‐Rong¹,Lin Yi‐Ming¹,Han Ti‐Yun²,Zhang De‐Kui¹²^ORCID

Affiliation:

1. Department of Gastroenterology The Second Hospital of Lanzhou University Lanzhou China

2. Key Laboratory of digestive diseases The Second Hospital of Lanzhou University Lanzhou China

3. Quality Control Department Gansu Provincial People's Hospital Lanzhou China

Funder

Natural Science Foundation of Gansu Province

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15488

Reference55 articles.

1. World Gastroenterology Organisation Global Guideline

2. Review: Clinical Management ofHelicobacter pyloriInfection in China

3. Helicobacter Pylori Infection

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose dual therapy versus bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta‐analysis;Journal of Digestive Diseases;2024-03

2. Helicobacter pylori antibiotic resistance in different regions of China: A systematic review and meta-analysis;World Chinese Journal of Digestology;2024-01-28

3. Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review;Helicobacter;2024-01

4. Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in Chile;Helicobacter;2024-01

5. Prevalence of Helicobacter pylori Antibiotic Resistance in Patients Enrolled in Guangzhou, China;Infection and Drug Resistance;2023-08